Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (691-700 of 1,145) with videos related to

Pageof 115
Sort By:
Virchows Archiv : an International Journal of Pathology|May 18, 2020
Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancersKatharina Möller, Anna Lena Wecker, Doris Höflmayer, et al.
BJU International|September 24, 2013
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasisNiccolo M Passoni, Harun Fajkovic, Evanguelos Xylinas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
Annals of Surgical Oncology|February 29, 2020
MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive LymphocytesChristoph Fraune, Eike Burandt, Ronald Simon, et al.
International Journal of Cancer|December 31, 2024
Life expectancy in rare histological prostate cancer subtypesCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Critical Care Medicine|January 8, 2025
Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney CancerCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Prostate Cancer and Prostatic Diseases|July 10, 2024
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortalityCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Clinical Genitourinary Cancer|February 18, 2024
Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all StagesCarolin Siech, Simone Morra, Lukas Scheipner, et al.
The Prostate|September 21, 2017
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerChristoph Burdelski, Rami Shihada, Andrea Hinsch, et al.
Urologic Oncology|September 24, 2013
Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?Luis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Pageof 115

Showing results (691-700 of 1,145) with videos related to

Sort By:
Pageof 115
Virchows Archiv : an International Journal of Pathology|May 18, 2020
Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancersKatharina Möller, Anna Lena Wecker, Doris Höflmayer, et al.
BJU International|September 24, 2013
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasisNiccolo M Passoni, Harun Fajkovic, Evanguelos Xylinas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
Annals of Surgical Oncology|February 29, 2020
MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive LymphocytesChristoph Fraune, Eike Burandt, Ronald Simon, et al.
International Journal of Cancer|December 31, 2024
Life expectancy in rare histological prostate cancer subtypesCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Critical Care Medicine|January 8, 2025
Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney CancerCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Prostate Cancer and Prostatic Diseases|July 10, 2024
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortalityCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Clinical Genitourinary Cancer|February 18, 2024
Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all StagesCarolin Siech, Simone Morra, Lukas Scheipner, et al.
The Prostate|September 21, 2017
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerChristoph Burdelski, Rami Shihada, Andrea Hinsch, et al.
Urologic Oncology|September 24, 2013
Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?Luis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Pageof 115